Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 1771 AL 1785

Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep-Wake Cycle Disorder

Alhusaini M, Eissa N, Saad AK, Beiram R, Sadek B.

Front Pharmacol. 2022 Jun 1;13:861094. doi: 10.3389/fphar.2022.861094. eCollection 2022.

Editorial: Deep Brain Stimulation Think Tank: Updates in Neurotechnology and Neuromodulation, Volume II

Ramirez-Zamora A, Giordano J, Halpern C, Butson C, Okun MS.

Front Hum Neurosci. 2022 Jun 1;16:912730. doi: 10.3389/fnhum.2022.912730. eCollection 2022.

The Mechanism and Function of Glia in Parkinson's Disease

Zhang X, Zhang R, Nisa Awan MU, Bai J.

Front Cell Neurosci. 2022 May 26;16:903469. doi: 10.3389/fncel.2022.903469. eCollection 2022.

Neuroinflammation and Immune Changes in Prodromal Parkinson's Disease and Other Synucleinopathies

Terkelsen MH, Klaestrup IH, Hvingelby V, Lauritsen J, Pavese N, Romero-Ramos M.

J Parkinsons Dis. 2022;12(s1):S149-S163. doi: 10.3233/JPD-223245.

Infections and Changes in Commensal Bacteria and the Pathogenesis of Parkinson's Disease

Shannon KM.

J Parkinsons Dis. 2022;12(s1):S45-S51. doi: 10.3233/JPD-223271.

Gatekeeping astrocyte identity

Cooper A, Berninger B.

Elife. 2022 Jun 20;11:e80232. doi: 10.7554/eLife.80232.

Sorting through the extensive and confusing roles of sortilin in metabolic disease

Mitok KA, Keller MP, Attie AD.

J Lipid Res. 2022 Aug;63(8):100243. doi: 10.1016/j.jlr.2022.100243. Epub 2022 Jun 18.

Central nervous system effects of 5-HT(7) receptors: a potential target for neurodegenerative diseases

Quintero-Villegas A, Valdés-Ferrer SI.

Mol Med. 2022 Jun 20;28(1):70. doi: 10.1186/s10020-022-00497-2.

Transcriptomics analysis of human iPSC-derived dopaminergic neurons reveals a novel model for sporadic Parkinson's disease

Krauskopf J, Eggermont K, Madeiro Da Costa RF, Bohler S, Hauser D, Caiment F, de Kok TM, Verfaillie C, Kleinjans JC.

Mol Psychiatry. 2022 Oct;27(10):4355-4367. doi: 10.1038/s41380-022-01663-y. Epub 2022 Jun 20.

Morphological basis of Parkinson disease-associated cognitive impairment: an update

Jellinger KA.

J Neural Transm (Vienna). 2022 Aug;129(8):977-999. doi: 10.1007/s00702-022-02522-4. Epub 2022 Jun 20.

Role of MST1 in the regulation of autophagy and mitophagy: implications for aging-related diseases

Shang H, VanDusseldorp TA, Ma R, Zhao Y, Cholewa J, Zanchi NE, Xia Z.

J Physiol Biochem. 2022 Nov;78(4):709-719. doi: 10.1007/s13105-022-00904-6. Epub 2022 Jun 21.

Emerging therapeutic developments in neurodegenerative diseases: A clinical investigation

Kumar D, Md Ashraf G, Bilgrami AL, Imtaiyaz Hassan M.

Drug Discov Today. 2022 Oct;27(10):103305. doi: 10.1016/j.drudis.2022.06.005. Epub 2022 Jun 18.

Targeting LRRK2 mutations in Parkinson's disease

Leśniak RK, Nichols RJ, Smith M, Montine TJ.

Future Med Chem. 2022 Aug;14(16):1167-1170. doi: 10.4155/fmc-2022-0102. Epub 2022 Jun 22.

Functional Movement Disorder and Parkinson's Disease Comorbidity: A Case Report

Ertürk S, Kardeş VÇ, Saraçli Ö, Demirel EA.

Turk Psikiyatri Derg. 2022 Summer;33(2):133-138. doi: 10.5080/u25740.

Role of post-translational modifications on the alpha-synuclein aggregation-related pathogenesis of Parkinson's disease

Yoo H, Lee J, Kim B, Moon H, Jeong H, Lee K, Song WJ, Hur JK, Oh Y.

BMB Rep. 2022 Jul;55(7):323-335. doi: 10.5483/BMBRep.2022.55.7.073.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias